Fasudil Completed Phase 2 Trials for Cardiovascular Disease (CVD) Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science2
clinicaltrials.gov IdentifierTitleDrugs
NCT03404843Red Blood Cell ATP Release and Vascular Function in Humans